Sacubitril/Valsartan Improves Cardiovascular Outcomes in Elderly Patients with Coronary Artery Disease and Hypertension: A Retrospective Cohort Study. (PubMed, J Vis Exp) - Oct 18, 2026 - "Both regimens were well-tolerated, with no severe adverse events reported. These findings indicate that sacubitril/valsartan is an effective and safe therapeutic option for elderly patients with CAD and hypertension, reducing long-term cardiovascular risk while improving blood pressure control and cardiac function."
Journal • Retrospective data • Cardiovascular • Coronary Artery Disease • Heart Failure • Hypertension • Myocardial Infarction
|